Optimization of self nanoemulsifying drug delivery system for poorly water-soluble drug using response surface methodology

References

• Gursoy RN, Benita S. (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother, 58:173–182.
   PubMed Web of Science ®Google Scholar
• Hauss DJ. (2007). Oral lipid-based formulations. Adv Drug Deliv Rev, 59:667–676.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res, 12:413–420.
   PubMed Web of Science ®Google Scholar
• Yu LX, Amidon GL, Polli JE, Zhao H, Mehta MU, Conner DP et al. (2002). Biopharmaceutics classification system: The scientific basis for biowaiver extensions. Pharm Res, 19:921–925.
   PubMed Web of Science ®Google Scholar
• Müllertz A, Ogbonna A, Ren S, Rades T. (2010). New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. J Pharm Pharmacol, 62:1622–1636.
   PubMed Web of Science ®Google Scholar
• Pouton CW. (2000). Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur J Pharm Sci, 11 Suppl 2:S93–S98.
   PubMed Web of Science ®Google Scholar
• Hauss DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA et al. (1998). Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci, 87:164–169.
   PubMed Web of Science ®Google Scholar
• Singh SK, Verma PR, Razdan B. (2010). Glibenclamide-loaded self-nanoemulsifying drug delivery system: Development and characterization. Drug Dev Ind Pharm, 36:933–945.
   PubMed Web of Science ®Google Scholar
• Mueller EA, Kovarik JM, van Bree JB, Grevel J, Lücker PW, Kutz K. (1994). Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation. Pharm Res, 11:151–155.
   PubMed Web of Science ®Google Scholar
• Lee CH, Olson P, Evans RM. (2003). Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology, 144:2201–2207.
   PubMed Web of Science ®Google Scholar
• Date AA, Nagarsenker MS. (2007). Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm, 329:166–172.
   PubMed Web of Science ®Google Scholar
• Dixit RP, Nagarsenker MS. (2008). Formulation and in vivo evaluation of self-nanoemulsifying granules for oral delivery of a combination of ezetimibe and simvastatin. Drug Dev Ind Pharm, 34:1285–1296.
   PubMed Web of Science ®Google Scholar
• Dixit RP, Nagarsenker MS. (2008). Self-nanoemulsifying granules of ezetimibe: Design, optimization and evaluation. Eur J Pharm Sci, 35:183–192.
   PubMed Web of Science ®Google Scholar
• Wang L, Dong J, Chen J, Eastoe J, Li X. (2009). Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci, 330:443–448.
   PubMed Web of Science ®Google Scholar
• Yoo JH, Shanmugam S, Thapa P, Lee ES, Balakrishnan P, Baskaran R et al. (2010). Novel self-nanoemulsifying drug delivery system for enhanced solubility and dissolution of lutein. Arch Pharm Res, 33:417–426.
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen ZQ, Zhang X, Feng NP, Zhao JH, Wu S et al. (2010). An improved formulation screening and optimization method applied to the development of a self-microemulsifying drug delivery system. Chem Pharm Bull, 58:16–22.
   PubMed Web of Science ®Google Scholar
• Holm R, Jensen IH, Sonnergaard J. (2006). Optimization of self-microemulsifying drug delivery systems (SMEDDS) using a D-optimal design and the desirability function. Drug Dev Ind Pharm, 32:1025–1032.
   PubMed Web of Science ®Google Scholar
• Furlanetto S, Cirri M, Piepel G, Mennini N, Mura P. (2011). Mixture experiment methods in the development and optimization of microemulsion formulations. J Pharm Biomed Anal, 55:610–617.
   PubMed Web of Science ®Google Scholar
• Basalious EB, Shawky N, Badr-Eldin SM. (2010). SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: Development and optimization. Int J Pharm, 391:203–211.
   PubMed Web of Science ®Google Scholar
• Taha EI, Samy AM, Kassem AA, Khan MA. (2005). Response surface methodology for the development of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Pharm Dev Technol, 10:363–370.
   PubMed Web of Science ®Google Scholar
• Granero GE, Ramachandran C, Amidon GL. (2005). Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutions. Drug Dev Ind Pharm, 31:917–922.
   PubMed Web of Science ®Google Scholar
• Holm R, Jørgensen EB, Harborg M, Larsen R, Holm P, Müllertz A et al. (2011). A novel excipient, 1-perfluorohexyloctane shows limited utility for the oral delivery of poorly water-soluble drugs. Eur J Pharm Sci, 42:416–422.
   PubMed Web of Science ®Google Scholar
• Nielsen FS, Gibault E, Ljusberg-Wahren H, Arleth L, Pedersen JS, Müllertz A. (2007). Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds. J Pharm Sci, 96:876–892.
   PubMed Web of Science ®Google Scholar
• Khoo SM, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. (1998). Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm, 167:155–164.
   Web of Science ®Google Scholar
• Zangenberg NH, Müllertz A, Kristensen HG, Hovgaard L. (2001). A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. Eur J Pharm Sci, 14:115–122.
   PubMed Web of Science ®Google Scholar
• Zangenberg NH, Müllertz A, Kristensen HG, Hovgaard L. (2001). A dynamic in vitro lipolysis model. II: Evaluation of the model. Eur J Pharm Sci, 14:237–244.
   PubMed Web of Science ®Google Scholar
• Larsen A, Holm R, Pedersen ML, Müllertz A. (2008). Lipid-based formulations for danazol containing a digestible surfactant, Labrafil M2125CS: In vivo bioavailability and dynamic in vitro lipolysis. Pharm Res, 25:2769–2777.
   PubMed Web of Science ®Google Scholar
• Pouton CW, Porter CJ. (2008). Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies. Adv Drug Deliv Rev, 60:625–637.
   PubMed Web of Science ®Google Scholar
• Small DM. (1968). A classification of biologic lipids based upon their interaction in aqeous systems. J Am Oil Chem Soc, 45:108–119.
   PubMed Web of Science ®Google Scholar
• Gershanik T, Benita S. (2000). Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm, 50:179–188.
   PubMed Web of Science ®Google Scholar
• Wakerly MG, Pouton CW, Meakin BJ, Morton FS. (1986). Self-emulsification of vegetable oil-nonionic surfactant mixtures. In: Phenomena in Mixed Surfactant Systems. Washington DC: American Chemical Society, 242–255.
   Google Scholar
• Craig DQM, Lievens HSR, Pitt KG, Storey DE. (1993). An investigation into the physico-chemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis. Int J Pharm, 96:147–155.
   Web of Science ®Google Scholar
• Constantinides PP. (1995). Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects. Pharm Res, 12:1561–1572.
   PubMed Web of Science ®Google Scholar
• Lewis GA, Chariot M. (1991). Nonclassical experimental-designs in pharmaceutical formulation. Drug Dev Ind Pharm, 17:1551–1570.
   Web of Science ®Google Scholar
• Eriksson L, Johansson E, Wikstrom C. (1998). Mixture design design generation, PLS analysis, and model usage. Chemometr Intell Lab, 43:1–24.
   Web of Science ®Google Scholar
• Afifi H, Karlsson G, Heenan RK, Dreiss CA. (2011). Solubilization of oils or addition of monoglycerides drives the formation of wormlike micelles with an elliptical cross-section in cholesterol-based surfactants: Astudy by rheology, SANS, and cryo-TEM. Langmuir, 27:7480–7492.
   PubMed Web of Science ®Google Scholar
• Kloer HU. (1987). Structure and biochemical effects of fenofibrate. Am J Med, 83:3–8.
   PubMed Web of Science ®Google Scholar
• Zung JB. (1991). Influence of alcohol addition on the Ã-CD:pyrene complex. J Phys Chem, 95:6701–6709.
   Web of Science ®Google Scholar
• Ratanabanangkoon P, Guzman H, Almarsson O, Berkovitz D, Tokarcyzk S, Straughn AB et al. (2008). A high-throughput approach towards a novel formulation of fenofibrate in omega-3 oil. Eur J Pharm Sci, 33:351–360.
   PubMed Web of Science ®Google Scholar
• Mohsin K, Long MA, Pouton CW. (2009). Design of lipid-based formulations for oral administration of poorly water-soluble drugs: Precipitation of drug after dispersion of formulations in aqueous solution. J Pharm Sci, 98:3582–3595.
   PubMed Web of Science ®Google Scholar
• Porter CJ, Charman WN. (2001). In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev, 50 Suppl 1:S127–S147.
   PubMed Web of Science ®Google Scholar